TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.
暂无分享，去创建一个
D. Neuberg | B. Ebert | P. Stojanov | R. Bejar | Rui Chen | H. Kantarjian | G. Garcia-Manero | K. Stevenson | D. Steensma | R. Stone | B. Caughey | G. Getz | Hui Wang | M. Bar‐Natan | J. Zaneveld | Allegra M. Lord | A. Pérez-Ladaga